Across TCGA pan-cancer cohorts, TRAV8-6 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TRAV8-6 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher TRAV8-6 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRAV8-6 expression acts as an unfavorable survival marker.

SKCM are the cancer types where TRAV8-6 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	III,IV	0.087	0.647	.013	3	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: TRAV8-6 tumor-vs-normal RNA expression · all TRAV8-6 data types